© 2021 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2021 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
December 01, 2021
PSMA PET is highly robust in identifying prostate cancer lesions which are otherwise deemed unremarkable.
October 08, 2021
Patients with hepatocellular carcinoma may benefit from early PET/CT imaging after transarterial radioembolization to predict treatment response and survival, a new study found.
October 06, 2021
Clinicians taking care of patients with high-risk prostate cancer being assessed for prostatectomy can use a positive PET scan as a true positive, but a negative scan cannot be used to exclude disease or inform nodal dissection.
October 01, 2021
Diagnostic Imaging sat down with medical physicist and CT expert Cynthia H. McCollough, PhD, to learn more about the history of CT and its expanding potential in medical imaging.
The approval represents the first major technological advance in CT in nearly a decade.
August 22, 2021
Screening for COVID-19 exposure, particularly for patients with cancer on active treatment, has become a priority during the pandemic.
August 16, 2021
Clinicians, especially those working in a region of high COVID-19 prevalence, should be aware that FDG PET/CT can detect lung and lymph node findings suggestive of COVID-19.
July 29, 2021
Both board-certified radiologists and radiology residents more appropriately suggested chest CT follow-up when using artificial intelligence with chest X-ray.
July 26, 2021
Measurements can help predict which tumors will respond to targeted therapies.
July 23, 2021
Take a quick look at Diagnostic Imaging's Top 5 stories of the week.